Board of Directors

• MBA, FCA

• Chartered accountant: PWC

• Management consultancy:

Reed Cons.

Managing and Financial DirectorJuliane Klein

• MBA Business and Marketing gExeter University

• 5 years Marketing at Unilever gLondon

• MD University of Sao Paulo, MBA gHarvard University

• 8 years Head of Department of Clinical gScience

• PhD in Human Physiology gNewcastle University

• 6 years postdoctoral experience

R&D DirectorMatthew Wilcox

Marketing DirectorLaura Pascoe

Operations DirectorAlessandra S. Dantas

Research and Development

•Tablet that you take before your main meal

•Forms a gel in the stomach•Gives the feeling fullness•Weight loss•Reduction in bile re-uptake•Therefore lowers cholesterol

Intellectual Property Time Line

20062005 20082007

University File Patent

University File for PCT

Prosecute in US, Canada, Europe, Japan, China and India

UK Patent Granted

Pipe Line•Product Line

▫Different Vehicles for Administration▫Different Flavours▫Different Doses

•Product Range▫Diabetes prevention and control ▫Specific cholesterol lowering▫Inhibition of Dietary Enzymes

Marketing and Sales Strategy

Overview, Drivers & CompetitionOverweight individuals UK

Men

Women

Currently trying to lose weight

MenWomen

Source: 200 16+ males and females interviewed Newcastle and London

• Food and supplement market £75 billion in Europe

Sales Strategy

• 1 Million trial packs• Loss leader- viral marketing

• Letters of intent

Operations

Operations - Production and Distribution Strategies

INDIA

Macclesfield

Nottingham

Operations Structure of Fybre ltd.

1

1-3

4-7

8

Timeline and Milestones for Production of 1 million sample packets of

Accelerol®Buy in & shipment of raw material for WeightWatchers trial

Stock piling and initial distribution to Boots, intensive advertising

Mon

ths

Accelerol® pressing and distribution to WeightWatchers trial

Accelerol ® available to purchase from Boots nationwide

Financial Projections

Your InvestmentPersonal investment: £20,000/Director

2008 20102007

Company set up (Ltd.) and University buy out: £80,000 (pref. shares) + 10% company

Company Equity Share

£80,000 for patent applications in Europe, USA, Canada, Japan, China, India

Possible exit through IPO or Trade Sale

Start of product trial through health clubs, Quality assurance

Start of large scale production and product launch UK

Initial Investment:

£800,000 for 40% equity

2011

Closing negotiations for whole sale to Danone, Unilever, Nestle

2009

BBSRC Entrepreneur Fellowship

1NE Research and Development Grant £100,000

2012 2013

22.5%

22.5%

22.5%

22.5%10%

Financial Projections

Production cost/unit: £0.50

Unit price whole sale: £2.50

Company value after 5 years: £31 M

Year 1 Year 2 Year 3 Year 4 Year 5

£795.000

£7.7M £12.6M £17.5M £28.5M

Thank You Sponsored by:

Balance Sheet Fybre ltd..xls

Cash Flow Fybre ltd.xls